283 related articles for article (PubMed ID: 15337983)
21. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
[TBL] [Abstract][Full Text] [Related]
22. Routine X-ray of the chest is not justified in staging of cutaneous melanoma patients.
Gjørup CA; Hendel HW; Pilegaard RK; Willert CB; Hölmich LR
Dan Med J; 2016 Dec; 63(12):. PubMed ID: 27910800
[TBL] [Abstract][Full Text] [Related]
23. Assessment of value of the sentinel lymph node biopsy in melanoma in children and adolescents and applicability of subcutaneous infusion anesthesia.
Topar G; Zelger B
J Pediatr Surg; 2007 Oct; 42(10):1716-20. PubMed ID: 17923201
[TBL] [Abstract][Full Text] [Related]
24. Staging patients with cutaneous malignant melanoma by same-day lymphoscintigraphy and sentinel lymph node biopsy: a single-institutional experience with emphasis on recurrence.
Gad D; Høilund-Carlsen PF; Bartram P; Clemmensen O; Bischoff-Mikkelsen M
J Surg Oncol; 2006 Aug; 94(2):94-100. PubMed ID: 16847917
[TBL] [Abstract][Full Text] [Related]
25. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Clark PB; Soo V; Kraas J; Shen P; Levine EA
Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
[TBL] [Abstract][Full Text] [Related]
26. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
[TBL] [Abstract][Full Text] [Related]
27. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
[TBL] [Abstract][Full Text] [Related]
28. Staging of regional lymph nodes in melanoma patients by means of 99mTc-MIBI scintigraphy.
Alonso O; Martínez M; Delgado L; De León A; De Boni D; Lago G; Garcés M; Fontes F; Espasandín J; Priario J
J Nucl Med; 2003 Oct; 44(10):1561-5. PubMed ID: 14530467
[TBL] [Abstract][Full Text] [Related]
29. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
Reintgen D; Rapaport D; Tanabe KK; Ross M
J Fla Med Assoc; 1997 Mar; 84(3):188-93. PubMed ID: 9143171
[TBL] [Abstract][Full Text] [Related]
30. Current staging and prognostic factors in melanoma.
Bartlett EK; Karakousis GC
Surg Oncol Clin N Am; 2015 Apr; 24(2):215-27. PubMed ID: 25769707
[TBL] [Abstract][Full Text] [Related]
31. The revised American Joint Committee on Cancer staging system for melanoma.
Thompson JA
Semin Oncol; 2002 Aug; 29(4):361-9. PubMed ID: 12170439
[TBL] [Abstract][Full Text] [Related]
32. Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.
Egger ME; Huber KM; Dunki-Jacobs EM; Quillo AR; Scoggins CR; Martin RC; Stromberg AJ; McMasters KM; Callender GG
J Am Coll Surg; 2013 Jul; 217(1):37-44; discussion 44-5. PubMed ID: 23791271
[TBL] [Abstract][Full Text] [Related]
33. High negative predictive value of slow lymphatic drainage on metastatic node spread detection in malignant limb and trunk cutaneous melanoma.
Cammilleri S; Jacob T; Rojat-Habib MC; Hesse S; Berthet B; Giorgi R; Bonerandi JJ; Mundler O
Bull Cancer; 2004; 91(7-8):E225-8. PubMed ID: 15381460
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy in patients with thick (= 4 mm) melanoma: a single-centre experience.
Cecchi R; Buralli L; Innocenti S; Seghieri G; De Gaudio C
J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):758-61. PubMed ID: 17567303
[TBL] [Abstract][Full Text] [Related]
35. Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis.
Nagaraja V; Eslick GD
Eur J Surg Oncol; 2013 Jul; 39(7):669-80. PubMed ID: 23571104
[TBL] [Abstract][Full Text] [Related]
36. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
37. S100 beta is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase.
Krähn G; Kaskel P; Sander S; Waizenhöfer PJ; Wortmann S; Leiter U; Peter RU
Anticancer Res; 2001; 21(2B):1311-6. PubMed ID: 11396205
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
39. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?
Vidal-Sicart S; Pons F; Puig S; Ortega M; Vilalta A; Martín F; Rull R; Palou JM; Castel T
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):362-6. PubMed ID: 12634963
[TBL] [Abstract][Full Text] [Related]
40. Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy.
Gold JS; Jaques DP; Busam KJ; Brady MS; Coit DG
Ann Surg Oncol; 2007 Jul; 14(7):2133-40. PubMed ID: 17453294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
